Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Strides Pharma Science Ltd
Press Release Jun 24 2022
Business
Jun 24 2022
5 min read

Press Release Jun 24 2022

Strides Pharma Science Limited has informed the Exchange about press release dated 24-Jun-2022 titled Biolexis and Akston Biosciences Announce Encouraging Top-Line Results from Phase II/III Trial of their Thermostable 2nd Gen COVID-19 Vaccine

View Attachment